In a recent study following nasal and plasma antibody responses one year after COVID-19 hospitalization, individuals who later received an injectable SARS-CoV-2 vaccine mounted systemic IgG and IgA recall responses and nasal IgG responses, but the nasal IgA responses were negligible 11. Here, CD79A is linked to COVID-19.